Clear One Health Plans (Clear One) and PacificSource Health Plans (PacificSource) have signed an agreement under which PacificSource is expected to acquire Clear One. Under the terms of
The FDA has not yet completed its review of Pfizer’s Biologics License Application (BLA) for Prevnar 13, (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the company’s candidate 13-valent
The FDA has informed Photocure that the new drug application (NDA) for Hexvix, for detection of non-invasive papillary bladder cancer, may be approved, pending approval of the PMA
The FDA has responded to Vion pharmaceuticals’ (Vion) Special Protocol Assessment (SPA) request to evaluate the phase III randomised trial, HOVON AML 92, sponsored by the Dutch-Belgian Cooperative
Vivus has submitted a New Drug Application (NDA) to the FDA seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance
Pfizer has discontinued A4021016 (also known as ADVIGO 1016), a phase 3 trial examining the effects of investigational compound, Figitumumab (CP-751,871), due to the study meeting predefined boundaries
Bionovo has published results from its study on the anti-tumor mechanism of BN107. The results, published in the International Journal of Cancer, describe the potential molecular mechanisms mediating
Soligenix (formerly known as DOR BioPharma) has reported the publication of an article in the January 2010 edition of Infection and Immunity, detailing the characteristics of several immunodominant
Advaxis has reported the results of phase I trial of ADXS11-001, the company’s lead vaccine candidate. The study showed 36 month survival in two of the 13 evaluable
The American Diabetes Association (ADA) has reported that its new clinical practice recommendations call for the addition of A1C test as a means of diagnosing diabetes and identifying
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.